BioConnect AG is a specialised consulting group in the Life Sciences sector. Founded in 1999, the company is focused on financial and strategic advisory services for Life Sciences companies in the areas of biotechnology, diagnostics, pharmaceuticals and medical technology. Due to its comprehensive network and a highly motivated team of experienced specialists in the fields of Finance/M&A, Venture Capital and Life Sciences, BioConnect AG has established itself as a leading advisory firm in the sector. BioConnects’ track record comprises more than  20 funding rounds and numerous strategic advisory mandates, including M&A. This enabled the company to become a reputable partner for Life Sciences companies with needs for financing or M&A advice. As a result of the high level of innovation and the ongoing consolidation process in the Medtech environment, BioConnect is also placing further emphasis on this particular sector.

Recent Transactions
– € 4.7m financing round for synthetic biology company Sloning Biotechnology
– € 13.5m venture financing for German medtech company 20/10 Perfect Vision AG
– € 6m venture financing for cardiac imaging company BMDSys
– Advised pes diagnosesysteme GmbH on the sale to Diasys Diagnostic Systems

For further information please refer to www.bioconnect.de

Klaus Nestler
klaus.nestler@bioconnect.de

BioConnect AG
Niedenau 36
60325 Frankfurt am Main
Tel.: +49 69 907 466 0
Fax: +49 69 907 466 20

back to top

DyoDelta Biosciences Ltd., is a London based company specialising in providing Business Development and Due Diligence support to companies and investors in the Pharma / Biotech sector.

DyoDelta Biosciences' team averages more than 20 years experience per person and more than 150 years of cumulative experience.  DyoDelta Biosciences has thousands of contacts at the senior corporate level worldwide and across the life sciences industry.  The team's executives have put together multiple types of deals, including R&D collaborations, strategic alliances, product licensing, acquisitions, disposals, financings and local geography partnering, with NPVs adding to billions of dollars.

DyoDelta Biosciences covers Europe, the US and Japan, in guiding and supporting pharma and biotech companies, investors, institutions and organisations in corporate transactions, evaluation and due diligence.

Corporate deals with pharma companies are key to progressing development, providing funding, validation and also the trigger to investors for either an IPO or further funding. 
DyoDelta Biosciences provides support to professional investors (funds) in the pharma and biotech sector the following areas:

• Market Research and Analysis
• Identification of suitable opportunities
• Deal Sourcing
• Industry Contacts
• Commercial & Technical Evaluation
• Due Diligence

For more information, please contact:
Dimitri F. Dimitriou, M.Sc.
Chief Executive Officer
DyoDelta Biosciences Ltd
Berkeley Square House
Berkeley Square
London W1J 6BD
UK

Tel:  +44 20 7396 5572
Fax:  +44 20 7396 5599

http://www.dyodelta.com/Investor_Support.html

back to top

Your Global Capitalization Partner
Katan Associates is a global advisory organization that provides capitalization strategies and a broad range of services to high growth, highly innovative life sciences companies, biotechnology firms and biomedical enterprises.

Based in the world’s leading centers for biotechnology and biomedicare, Katan Associates brings together specialists from a diverse range of corporate and commercial backgrounds to advise firms on long term growth and capitalization solutions.

Katan Associates focuses on five core areas of specialization in helping firms achieve their business growth.

• Strategy Formulation
• International Business Development
• Investment Banking / Venture Capital
• Government and Industry Advisory
• Mergers and Acquisitions

Katan provides businesses and management teams with the tools and the infrastructure to grow and expand their business.

To find out more, please visit our website at www.katanassociates.com

Or contact Seth Yakatan, Partner, at 323.356.6321 or seth@katanassociates.com

back to top